These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nebivolol: a selective beta(1)-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms. Ignarro LJ; Byrns RE; Trinh K; Sisodia M; Buga GM Nitric Oxide; 2002 Sep; 7(2):75-82. PubMed ID: 12223176 [TBL] [Abstract][Full Text] [Related]
4. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide. Gupta S; Wright HM Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089 [TBL] [Abstract][Full Text] [Related]
5. Characterization of nitric oxide release by nebivolol and its metabolites. Maffei A; Vecchione C; Aretini A; Poulet R; Bettarini U; Gentile MT; Cifelli G; Lembo G Am J Hypertens; 2006 Jun; 19(6):579-86. PubMed ID: 16733229 [TBL] [Abstract][Full Text] [Related]
6. Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells. Evangelista S; Garbin U; Pasini AF; Stranieri C; Boccioletti V; Cominacini L Pharmacol Res; 2007 Apr; 55(4):303-9. PubMed ID: 17280840 [TBL] [Abstract][Full Text] [Related]
7. Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation. Maffei A; Di Pardo A; Carangi R; Carullo P; Poulet R; Gentile MT; Vecchione C; Lembo G Hypertension; 2007 Oct; 50(4):652-6. PubMed ID: 17664392 [TBL] [Abstract][Full Text] [Related]
8. Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker. Ignarro LJ Blood Press Suppl; 2004 Oct; 1():2-16. PubMed ID: 15587107 [TBL] [Abstract][Full Text] [Related]
9. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade. Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309 [TBL] [Abstract][Full Text] [Related]
10. Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta. Rozec B; Quang TT; Noireaud J; Gauthier C Br J Pharmacol; 2006 Apr; 147(7):699-706. PubMed ID: 16474420 [TBL] [Abstract][Full Text] [Related]
12. The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery. Georgescu A; Pluteanu F; Flonta ML; Badila E; Dorobantu M; Popov D Eur J Pharmacol; 2005 Jan; 508(1-3):159-66. PubMed ID: 15680267 [TBL] [Abstract][Full Text] [Related]
13. Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells. Brehm BR; Wolf SC; Bertsch D; Klaussner M; Wesselborg S; Schüler S; Schulze-Osthoff K Cardiovasc Res; 2001 Feb; 49(2):430-9. PubMed ID: 11164853 [TBL] [Abstract][Full Text] [Related]
14. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney. Kakoki M; Hirata Y; Hayakawa H; Nishimatsu H; Suzuki Y; Nagata D; Suzuki E; Kikuchi K; Nagano T; Omata M Hypertension; 1999 Jan; 33(1 Pt 2):467-71. PubMed ID: 9931149 [TBL] [Abstract][Full Text] [Related]
15. Nebivolol induces calcium-independent signaling in endothelial cells by a possible beta-adrenergic pathway. Gosgnach W; Boixel C; Névo N; Poiraud T; Michel JB J Cardiovasc Pharmacol; 2001 Aug; 38(2):191-9. PubMed ID: 11483868 [TBL] [Abstract][Full Text] [Related]